It looks like nothing was found at this location. Maybe try a search or one of the links below?
Recent Posts
- New Policy Brief: What is the Risk of “Captagon” and Other Pill-Pressed Stimulants in Tennessee?
- (Podcast) The Buprenorphine Waiver is Gone…Now What?
- (Podcast) Decoding Autopsies: What Medical Examiners See That Others Miss
- (Podcast) How Does Tennessee Regulate Cannabinoids?
- (Podcast) How Law Enforcement is Rethinking Mental Health and Addiction
Archives
Categories
Tags
ADHD
alternatives to incarceration act
amphetamine
Behavioral Therapy
big pharma
buprenorphine
business
captagon
contamination
covid
criminal justice reform
data
economics
emergency department
fatalities
fentanyl
forensic
gibson
harm reduction
Hikma
hospital
jail
leadership
mat
medical examiner
moud
musicians
naloxone
needle exchange
non-opioid
ONEbox
opioid abatement council
opioid abatement settlement
opioid settlement
overdose
pharmaceutical
prescription drugs
private sector
reentry success act
remediation
ssp
state of emergency
syringe service program
telehealth
trend
Pages
- #14081 (no title)
- Action Areas
- Contact
- Criminal Justice and Substance Use Disorder Dashboard
- Events
- Mobile Menu
- My Calendar
- ninja_forms_preview_page
- SMART
- SMART Policy Network
- Data Dashboards
- Guest Columns
- Operations Committee
- Policy Briefs
- Better Broadband for Better Health
- Broadband Expansion
- Continuity of Care
- Harm Reduction
- MAT/MATE Acts
- Naloxone Access
- Opioid Overdose Deaths in Tennessee
- Preventing Youth Substance Misuse in Tennessee
- Prior Authorizations and Addiction Treatment
- Substance Misuse and Incarceration in Tennessee
- Telehealth Improves Access to Treatment for Substance Use Disorder
- The Cost of Stigma
- The Need for Point-of-Care Testing of All Illicit Substances
- What is the Risk of Captagon?
- Xylazine Facts
- Steering Committee
- Staff
- Technical Assistance